fexofenadine + quinidine sulfate

Fexofenadine + quinidine sulfate is a theoretical combination of two distinct drugs with no known marketed or clinically recognized product containing both agents together as active ingredients. **Fexofenadine** is a selective, non-sedating antihistamine acting as a peripheral H1-receptor antagonist, indicated primarily for the symptomatic relief of allergic rhinitis and chronic urticaria, and works by blocking the effects of histamine at H1-receptor sites. **Quinidine sulfate** is a class Ia antiarrhythmic and antimalarial agent used for the management of atrial fibrillation, flutter, and certain ventricular arrhythmias; it acts primarily by blocking voltage-gated sodium channels in cardiac tissue, resulting in prolonged action potentials, as well as antagonizing alpha-adrenergic and anticholinergic activity. No evidence supports an approved therapeutic indication, clinical use, or development program for a combination of these two agents.